MA45177A - Traitement de la maladie de parkinson - Google Patents

Traitement de la maladie de parkinson

Info

Publication number
MA45177A
MA45177A MA045177A MA45177A MA45177A MA 45177 A MA45177 A MA 45177A MA 045177 A MA045177 A MA 045177A MA 45177 A MA45177 A MA 45177A MA 45177 A MA45177 A MA 45177A
Authority
MA
Morocco
Prior art keywords
parkinson
disease
treatment
Prior art date
Application number
MA045177A
Other languages
English (en)
Other versions
MA45177B1 (fr
Inventor
Gajanan Uttamrao Chidrewar
Trinadha Rao Chitturi
Nitin Krishnaji Damle
Sanjay Nandlalji Mandhane
Sameer Vishwanath Mehetre
Prabal Sengupta
Manoj Atmaramji Upadhya
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Priority claimed from PCT/IN2017/050224 external-priority patent/WO2017208267A1/fr
Publication of MA45177A publication Critical patent/MA45177A/fr
Publication of MA45177B1 publication Critical patent/MA45177B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA45177A 2016-06-02 2017-06-02 Traitement de la maladie de parkinson MA45177B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621019087 2016-06-02
PCT/IN2017/050224 WO2017208267A1 (fr) 2016-06-02 2017-06-02 Traitement de la maladie de parkinson

Publications (2)

Publication Number Publication Date
MA45177A true MA45177A (fr) 2019-04-10
MA45177B1 MA45177B1 (fr) 2022-08-31

Family

ID=83280007

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45177A MA45177B1 (fr) 2016-06-02 2017-06-02 Traitement de la maladie de parkinson

Country Status (1)

Country Link
MA (1) MA45177B1 (fr)

Also Published As

Publication number Publication date
MA45177B1 (fr) 2022-08-31

Similar Documents

Publication Publication Date Title
EP3515505A4 (fr) Traitement vaa de la maladie de huntington
MA49402A (fr) Polynucléotides aadc pour le traitement de la maladie de parkinson
EP3645121A4 (fr) Méthodes de traitement de la maladie de huntington
EP3644996A4 (fr) Procédés de traitement de la maladie de huntington
MA41115A (fr) Procédé de traitement de la maladie d'alzheimer
EP3370721A4 (fr) Traitement de l'ostéoarthrite
MA45149A (fr) Méthodes de traitement de la maladie d'alzheimer
EP3490582A4 (fr) Méthodes et compositions de traitement de maladie.
EP3458589A4 (fr) Compositions et méthodes de traitement de la maladie de huntington
EP3291815A4 (fr) Méthodes de traitement d'une maladie neurodégénérative
EP3452166A4 (fr) Stimulation intranasale pour le traitement de la maladie de la glande de meibomius et de la blépharite
EP3528852A4 (fr) Méthodes et compositions pour le traitement de la maladie de fabry
LT3463351T (lt) Parkinsono ligos gydymas
EP3294345A4 (fr) Formulations de tpp1 et méthodes de traitement de la maladie cln2
EP2978446A4 (fr) Procédés et agents pour le traitement de la maladie d'alzheimer
EP3454793A4 (fr) Bobines de traitement d'anévrisme
EP3833435A4 (fr) Détermination de la maladie de parkinson
MA46353A (fr) Méthodes de traitement de l'infertilité féminine
HUE064813T2 (hu) NK-3 receptor antagonisták testzsírfelesleg terápiás vagy kozmetikai kezelésére
EP3546449A4 (fr) Dérivé de pipéridine -2,6-dicétone et traitement de la maladie de crohn
EP3458062A4 (fr) Traitement de la douleur
PT3458045T (pt) Ebselen para uso no tratamento da doença de ménière
SI3458067T1 (sl) Zdravljenje nevroloških obolenj
EP3398614A4 (fr) Agent pour la prévention et/ou le traitement de la maladie d'alzheimer
MA41782A (fr) Traitement de patients atteints de diabète de type 2